switching from compounded tirzepatide to zepbound (Tirzepatide): A Q&A on the Mounjaro-Like Weight Loss Drug Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

Patient Impact and Safety Concerns The end of compounded semaglutide availability raises concerns about patient access and safety

For the rat, the highest dose was, on a mg/m2 basis, about 2.5 the MRHD (Calculations based on a 60 kg patient)

Many also ignore basic FSSAI certifications, risking their health on imported, unverified grey-market products

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

The company had cut prices in November 2025 by 37% to expand the access of its chronic weight management therapy and counter Mounjaro which was launched in March 2025

BodySites Semaglutide Weight Loss Program provides a structured framework that supports these changes, offering patients the best chance for long-term success